Ncf2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-gene
| Gene Symbol | NCF2 |
| Full Name | Neutrophil Cytosolic Factor 2 |
| Chromosomal Location | 1q25.3 |
| NCBI Gene ID | 4689 |
| OMIM | 608512 |
| Ensembl ID | ENSG00000116701 |
| UniProt | P19878 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Chronic Granulomatous Disease |
::
NCF2 (Neutrophil Cytosolic Factor 2), also known as p67phox, is a key component of the NADPH oxidase complex that generates superoxide anions in phagocytic cells. While primarily studied in immune cells, NCF2 and the NADPH oxidase system are increasingly recognized as important contributors to oxidative stress in neurodegenerative diseases, particularly in microglia-mediated neuroinflammation.
NCF2 encodes the p67phox subunit of the NADPH oxidase complex. This multi-subunit enzyme complex is responsible for the production of reactive oxygen species (ROS) through the one-electron reduction of oxygen.
The NADPH oxidase complex consists of:
NCF2/p67phox plays critical roles in:
Microglial NADPH oxidase is chronically activated in Alzheimer's disease brain, contributing to oxidative stress and neuroinflammation. NCF2 expression is upregulated in microglia surrounding amyloid plaques, and NADPH oxidase-derived ROS may accelerate amyloid pathology and neuronal damage.
NADPH oxidase plays a key role in microglial activation and dopaminergic neuron vulnerability in PD. Studies show increased NCF2 expression in activated microglia in PD brain and animal models. Inhibition of NADPH oxidase is protective in PD models.
Mutations in NCF2 cause autosomal recessive chronic granulomatous disease (CGD), characterized by defects in phagocyte oxidative burst and recurrent infections.
NCF2 is primarily expressed in neutrophils, monocytes, and microglia. In the brain, NCF2 is expressed in microglia, particularly in regions associated with neurodegenerative pathology. Expression is low in resting microglia but increases dramatically upon activation.
The study of Ncf2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.